Training in Cancer Pharmacology

癌症药理学培训

• 批准号: 7681012
• 负责人: LEROY F LIU
• 金额: $ 12.94万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-29 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7681012
• 关键词: Training; cancer pharmacology

DESCRIPTION (provided by applicant): The Pharmacology Department at the Robert Wood Johnson Medical School (RWJMS) in collaboration with the faculty at the Ernest Mario School of Pharmacy at Rutgers University (EMSOP, RU) and the Cancer Institute of New Jersey (CINJ), are requesting funds to support a training program in cancer pharmacology for postdoctoral and predoctoral fellows. The collaborative program brings together faculty from the three participating institutions with a common interest in cancer pharmacology. The major strengths of the program include the top quality of the faculty, existing research collaborations between the faculty and the opportunity for the trainees for research in both basic as well as applied cancer pharmacology. Additionally, the trainees will be able to: a) serve as interns in the pharmaceutical industry that are located in the immediate vicinity of the campus around Piscataway and New Brunswick, NJ to become familiar with various aspects of pre clinical drug development and cancer pharmacology in the industrial setting and b) observe first hand the role cancer pharmacology plays in clinical oncology practice. The training grant will be a unique opportunity to attract talented candidates and train them to become future research scientists in cancer pharmacology. The predoctoral trainees will be enrolled in the Cellular and Molecular Pharmacology Graduate Program administered by the Pharmacology Department at RWJMS that involves both course work and laboratory research. Postdoctoral trainees, in addition to basic laboratory research in cancer pharmacology with one of the faculty, will be required to take two of the elective courses related to cancer and cancer pharmacology offered in the Department of Pharmacology. The faculty mentors of this training program from the three institutions have a broad range of research interests that span cell cycle control, basic mechanisms of tumorigenesis, understanding mechanisms of drug action and resistance, cancer gene therapy and non-invasive in vivo imaging, with a shared interest in cancer pharmacology

描述(由申请人提供)：罗伯特·伍德·约翰逊医学院(RWJMS)药理学系与罗格斯大学欧内斯特·马里奥药学院(EMSOP，RU)和新泽西癌症研究所(CINJ)的教职员工合作，正在申请资金，以支持针对博士后和博士后研究员的癌症药理学培训计划。这项合作计划汇集了三个参与机构的教职员工，他们对癌症药理学有着共同的兴趣。该计划的主要优势包括一流的教师质量，教师之间现有的研究合作，以及为受训人员提供在基础和应用癌症药理学方面进行研究的机会。此外，受训人员将能够：a)在位于新泽西州皮斯卡塔韦和新不伦瑞克校园附近的制药行业实习，熟悉工业环境中临床前药物开发和癌症药理学的各个方面，以及b)第一手观察癌症药理学在临床肿瘤学实践中所起的作用。培训补助金将是一个独特的机会，可以吸引有才华的候选人，并将他们培养成未来的癌症药理学研究科学家。这些博士前实习生将参加由RWJMS药理学系管理的细胞和分子药理学研究生课程，该课程包括课程工作和实验室研究。博士后实习生，除了其中一个学院的癌症药理学基础实验室研究外，还将被要求参加药理学系提供的与癌症和癌症药理学有关的两门选修课。来自这三个机构的这一培训项目的教师有广泛的研究兴趣，包括细胞周期控制、肿瘤发生的基本机制、了解药物作用和耐药性的机制、癌症基因治疗和非侵入性体内成像，以及对癌症药理学的共同兴趣。

项目成果

The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

• DOI: 10.1016/j.yexcr.2008.07.028
• 发表时间: 2008-10-15
• 期刊: Experimental cell research
• 影响因子: 3.7
• 作者: Lin SY;Yang J;Everett AD;Clevenger CV;Koneru M;Mishra PJ;Kamen B;Banerjee D;Glod J
• 通讯作者: Glod J